Skip to main content
Data in Brief logoLink to Data in Brief
. 2022 Dec 8;46:108811. doi: 10.1016/j.dib.2022.108811

Dataset of dual RNA-seq mapping in visceral leishmaniasis: Inquiry on parasite transcripts in human blood transcriptome upon Leishmania infantum infection

Ellen Gomes a, Luana Aparecida Rogerio a, Nayore Tamie Takamiya a, Caroline Torres a, João Santana da Silva b, Roque Pacheco Almeida c, Sandra Regina Maruyama a,⁎
PMCID: PMC9792721  PMID: 36582994

Abstract

This dataset is related to the article “Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection” by S.R. Maruyama, C.A. Fuzo, A.E.R. Oliveira, L.A. Rogerio, N.T. Takamiya, G. Pessenda, E.V. de Melo, A.M. da Silva, A.R. Jesus, V. Carregaro, H.I. Nakaya, R.P. Almeida and J.S. da Silva. Frontiers in Immunology, 2022. Through the reuse of raw sequencing data, we generated original dataset by performing a dual RNA-seq mapping procedure to survey the parasite transcripts found in RNA-seq samples from blood of visceral leishmaniasis patients. Diseased patients with active infection displayed the highest number of reads mapped to L. infantum genome. Even after six months later of the treatment, when the patients were considered cured, parasite reads were still detected. Parasite reads were also detected in asymptomatic individuals. The original dual RNA-seq alignment read count data provided here can be further explored to evaluate either host or parasite transcripts.

Keywords: Dual RNA-seq, Host/parasite interaction, Leishmania, Leishmaniasis, blood transcriptomics


Specifications Table

Subject Biological science
Specific subject area Bioinformatics and Transcriptomics
Type of data Tables, spreadsheets, text files
How the data were acquired The mRNA-seq data from blood of nineteen individuals were retrieved from the gene expression study under accession number E-MTAB-11047 available on ArrayExpress repository.
Data format Raw sequence files (re-used from E-MTAB-11047)
Raw read count files (original)
Analyzed (original)
Filtered (original)
Description of data collection Raw fastq files of samples classified according to the L. infantum infection state as PD0 (active disease state, before treatment), PD180 (cured disease state, 180 days after treatment) or A (asymptomatic individuals, no clinical signs) were analyzed. Reads were checked for quality control and trimmed. High quality reads were mapped to the concatenated human and Leishmania infantum genomes using STAR Aligner. The option "quantMode GeneCounts" within STAR was used to perform reads counting. STAR Output tables with read counts were analyzed focused on alignment in genome parasite to produce a survey for parasite gene transcription dataset (original data).
Data source location The raw mRNA-seq data are available on ArrayExpress, E-MTAB-11047, 2022, https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-11047. SANDRA MARUYAMA (submitter). "Bulk mRNA-seq of blood samples of visceral leishmaniasis patients during active disease and after treatment (cured), asymptomatic individuals and healthy uninfected control volunteers." Accessed 26 May 2022 (Re-used).
The original data (raw, processed, filtered and analyzed) are available at Mendeley Data Repository: “Dual mapping of RNA-seq samples from blood of visceral leishmaniasis patients”. DOI:10.17632/2xwjzjzvyn.1
Data accessibility Raw sequencing data (fastq files) at Functional Genomics Repository (ArrayExpress) under accession number E-MTAB-11047:
https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-11047
Raw read count files and processed/analyzed data of dual mapping procedure:
Mendeley Data Repository, Version 1 available at
https://data.mendeley.com/datasets/2xwjzjzvyn
Related research article S.R. Maruyama, C.A. Fuzo, A.E.R. Oliveira, L.A. Rogerio, N.T. Takamiya, G. Pessenda, E.V. de Melo, A.M. da Silva, A.R. Jesus, V. Carregaro, H.I. Nakaya, R.P. Almeida and J.S. da Silva (2022). Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection. Front. Immunol. 13:784463. doi:10.3389/fimmu.2022.784463[1].

Value of the Data

  • •

    The dataset of parasite transcripts in different outcomes of Leishmania infantum infection can guiding further studies for biomarkers prediction and validation.

  • •

    Mining RNA-seq data of infected hosts to search reads from pathogens can reveal information about gene transcription of Leishmania infantum parasites.

  • •

    Research field of parasite/host interaction in Leishmaniases can explore the data to gather insights from a dynamic perspective of the infection and the disease.

1. Objective

Leishmania infections in humans target host tissues such as skin, spleen, liver and bone marrow. These infections are not characterized by parasitemia, except for patients co-infected with HIV, who present a higher load of parasites in blood [2]. Leishmania parasites are present in peripheral blood, however due to the low load, they can be found in blood samples only through sensitive nucleic acid detection methods such as qPCR (quantitative polymerase chain reaction) [3]. Elsewhere, we analyzed blood transcriptomes of visceral leishmaniasis patients infected with L. infantum compared to the non-diseased groups: asymptomatics (no clinical signs of VL, but present positive antibody detection for L. infantum) cured (six months after successful treatment) and uninfected health controls [1]. Because the data were obtained through RNA sequencing (RNA-seq), a burning question arises: Are Leishmania transcripts detected in the RNA-seq data of blood from VL patients?

In order to survey the parasite transcripts found in blood from patients with active infection, six months after treatment (cured), as well as in asymptomatic individuals, here our aim was to perform a dual RNA-seq mapping analysis through re-using of previous RNA-seq data [1].

2. Data Description

The dataset presented here is a combination of data mining and original data production. It was built through reusing raw sequencing data (fastq files) from Maruyama et al. study [1] (available at https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-11047) followed by an original analysis through dual RNA-seq mapping (available at https://data.mendeley.com/datasets/2xwjzjzvyn). Approximately 79% of reads mapped uniquely to the human/L. infantum concatenated genome. The survey for parasite transcription data yielded an original dataset comprised by a total of 2,601 reads mapped to 1,419 L. infantum genes distributed across the 36 chromosomes of parasite genome (Supplementary Table 1). The data are summarized in Table 1 and Table 2 and described as follow.

Table 1.

Summary of read counts and mapped reads to host and parasite concatenated genomes.

Group Samples N° of readsa % of mapped readsb N° of reads mapped to L. infantum N° of L. infantum mapped genes N° of reads mapped to human N° of human mapped genes
PD0 P6D0 34,881,495 73.09% 638 536 25,497,422 25,157
P8D0 36,915,299 71.80% 3 3 26,508,362 23,301
P11D0 24,646,435 80.02% 162 143 19,722,597 25,170
P20D0 27,840,339 79.67% 357 223 22,182,786 24,097
P24D0 32,646,169 77.03% 28 23 25,149,249 26,419
P29D0 30,364,552 82.36% 5 5 25,011,003 24,222
P31D0 26,775,996 79.14% 19 19 21,191,752 24,367
P42D0 27,861,819 78.87% 230 121 21,976,994 20,950
P43D0 31,078,212 79.39% 47 42 24,674,666 24,047
P46D0 26,935,489 76.33% 108 58 21,004,794 23,832
PD180 P6D180 35,710,907 76.25% 0 0 27,230,094 24,160
P8D180 29,459,895 83.16% 0 0 29,499,521 23,401
P11D180 27,208,817 80.31% 28 28 21,853,829 25,431
P20D180 31,972,955 77.96% 45 45 51,663,789 49,213
P24D180 28,259,473 78.56% 0 0 22,201,489 25,650
P29D180 32,539,028 77.94% 0 0 25,364,093 26,175
P3D180 33,901,027 72.51% 25 22 24,584,175 23,957
P42D180 24,511,867 79.78% 36 36 19,556,829 23,298
P43D180 26,096,811 80.48% 28 28 21,004,794 23,832
P46D180 26,478,354 79.57% 37 36 21,070,772 23,905
Asymptomatic A1 26,333,879 82.62% 15 15 21,757,658 23,654
A6 28,348,081 83.51% 25 25 23,674,070 23,657
A7 22,745,866 77.11% 56 54 17,540,399 25,243
A8 27,372,410 81.45% 13 13 22,295,025 24,782
A9 33,194,383 81.04% 18 18 26,902,178 24,815
A11 23,480,413 73.73% 43 43 17,314,267 25,342
A13 33,675,198 83.75% 26 26 28,206,021 24,477
A17 27,350,834 79.61% 29 29 21,775,748 25,387
A24 26,352,907 80.13% 40 40 21,116,934 24,304
a

After trimming and quality control procedure.

b

Uniquely mapped reads.

Table 2.

Parasite genes identified in RNA-seq data of blood from visceral patients (PD0), cured VL (PD180) and asymptomatic individuals (A). Only genes found in three or more samples are displayed (icon ∩: intersection).

Group Samples Gene ID Average N° of reads Chromosome Location Gene Description Gene Type
PD0s P20D0 ∩ P42D0 ∩ P43D0 ∩ P46D0 LINF_260017300 2.75 26 hypothetical protein - conserved protein coding gene
P11D0 ∩ P20D0 ∩ P6D0 LINF_320009600 1.00 32 40S ribosomal protein S2 protein coding gene
P20D0 ∩ P43D0 ∩ P6D0 LINF_030011500 1.00 3 hypothetical protein - conserved protein coding gene
LINF_160007900 1.00 16 inositol 1 -4 -5-trisphosphate receptor - putative protein coding gene
P31D0 ∩ P46D0 ∩ P6D0 LINF_060013700 4.50 6 hypothetical protein - conserved protein coding gene
P11D0 ∩ P20D0 ∩ P43D0 LINF_200021000 2.00 20 40S ribosomal protein S11 - putative protein coding gene
PD180s P11D180 ∩ P20D180 ∩ P42D180 LINF_340027900 1.00 32 Kelch motif/Galactose oxidase - central domain containing protein - putative protein coding gene
P11D180 ∩ P20D180 ∩ P43D180 LINF_320011300 1.00 32 hypothetical protein - conserved protein coding gene
P20D180 ∩ P43D180 ∩ P46D180 LINF_280021400 1.00 28 hypothetical protein - conserved protein coding gene
LINF_260017300 1.33 26 hypothetical protein - conserved protein coding gene
Asymptomatics A1 ∩ A11 ∩ A6 A7 LINF_060013700 1.25 6 hypothetical protein - conserved protein coding gene
A17 ∩ A6 ∩ A7 LINF_320011300 1.00 32 hypothetical protein - conserved protein coding gene
A13 ∩ A17 ∩ A8 LINF_130022000 1.00 13 dynein heavy chain - putative protein coding gene

Table 1: all samples from PD0 group (patients with active disease before treatment) presented reads aligned to L. infantum genome totaling 1,597 reads aligned to 1,173 genes (∼ 1.4 reads/transcript). In the PD180 group (same patients after six months of treatment), where individuals were considered clinically cured, reads were detected in much lower number than PD0 group, but still 6 out of 10 samples presented read alignment (P11_D180, P20_D180, P31_D180, P42_D180, P43_D180 and P46_D180). Among diseased state/active infection samples, P6D0 presented the highest read count (638) and six months later (P6D180) no parasite read was found. Except for P31 individual, all other patients presented important reduction of parasite read counts after six months of the treatment (PD0 samples compared to PD180 samples). Parasite reads were also detected in all samples from asymptomatic group, comprising 265 reads mapped to 263 genes (∼ 1 read/transcript).

Table 2: none parasite gene presented read mapping across all samples (i.e., shared among all gene lists). Thirteen L. infantum genes presented read alignment at least in three samples within a group. Most of them (8) are annotated as “hypothetical protein – conserved”, i.e., with no function described. The others presented role in different aspects of cellular metabolism, such as protein synthesis (LINF_320009600 and LINF_200021000), calcium signaling (LINF_160007900), oxidation (LINF_340027900) and microtubule motor activity (LINF_130022000). Seven out of 13 genes were detected in RNA-seq of PD0 group, i.e., in human blood upon L. infantum infection (LINF_260017300, LINF_320009600, LINF_030011500, LINF_160007900, LINF_060013700, LINF_200021000 and LINF_340027900).

3. Experimental Design Materials and Methods

Here, we re-used raw fastq files from E-MTAB-11047 study [1] and presented original data from the dual RNA-seq mapping approach performed in the blood RNA-seq data of visceral leishmaniasis patients before (active disease state, PD0 group, n=10, being 5 women and 5 men) and after six months of the treatment (cured disease state, PD180 group, n=10, the same 5 women and 5 men). Also, the same procedure was performed in samples from asymptomatic individuals (A group, n=9, being 3 women and 6 men). The age in PD0 and PD180 groups ranged from 1 to 51 years-old for women patients and from 10 to 44 years-old for men patients (age mean values 14,5 and 24 years-old, respectively). For asymptomatic group the age ranged from 3 to 30 years-old for women and from 6 to 42 years old (age mean values 12 and 21 years-old respectively).

These 19 individuals were grouped based on the phase of visceral leishmaniasis disease. Patients presenting fever, weight loss, hepatosplenomegaly, and low leukocyte and platelet counts with confirmed visceral leishmaniasis diagnosis by direct observation of Leishmania parasites in bone marrow aspirate or positive culture in Novy–MacNeal–Nicolle (NNN) medium and positive rK39 serological test (Kalazar Detect Rapid Test, InBios International Inc. Seattle, WA) was considered as patients with active visceral leishmaniasis disease (PD0). These patients were treated with meglumine antimoniate (Glucantime®) and/or liposomal amphotericin B (AmBisome®) and after 180 days the patients were considered clinically cured (PD180). Healthy individuals who presented normal hematologic indices and neither clinical signs nor symptoms of VL but positive reactions to leishmanial antigens (Montenegro Skin test and rK39 serological test) were considered asymptomatic (A). All VL patients were negative for hepatitis B and C viruses and HIV, and also for bacterial infections or other parasites. Of note, the individuals enrolled in this study are from Sergipe state, located in the Northeast region of Brazil, that is not endemic for Malaria.

A concatenated host/parasite (human/L. infantum) reference genome was used for read alignment (dual RNA-seq mapping). The read count output files from STAR aligner (available at Mendeley Data, Reserved DOI:10.17632/2xwjzjzvyn.1) were compiled into one table (Supplementary Table 1) and used to survey specifically the parasite transcripts. To identify the parasite transcripts that were consistently found across the samples, Venn diagrams were performed using samples’ gene lists.

3.1. RNA isolation and mRNA sequencing

Peripheral blood samples were collected using BD Vacutainer® tubes for hematologic tests and PAXgene Blood RNA tubes for RNA isolation. Total RNA was extracted from whole blood with the PAXgene Blood RNA Kit followed by globin mRNA depletion using the GLOBINclear™ Human Kit to enhance the samples for RNA from leukocytes. Concentration, purity and integrity were determined using Qubit™ 3.0 Fluorometer with a Qubit™ RNA HS Assay Kit, NanoDrop™ 1000 Spectrophotometer by absorbance measurements (nm) of the 260/280 and 260/230 ratios and Agilent 2100 Bioanalyzer using a Bioanalyzer RNA 6000 Nano assay, respectively. Samples with a RIN > 7 were submitted for RNA sequencing. mRNA sequencing was performed at the Genomics Center of the Laboratory of Animal Biotechnology, ESALQ, University of São Paulo, Piracicaba, Brazil, using Illumina sequencing technology. Polyadenylated cDNA libraries were prepared with 300 ng of RNA depleted from globin mRNAs using the TruSeq® Stranded RNA Sample Preparation Kit. Paired-end sequencing was performed using a HiSeq SBS V4 kit (2 × 100 or 2 × 125 reads) in a HiSeq 2500 sequencer, yielding approximately 71 million reads for each mRNA-seq library.

3.2. Data analyses

A total of 29 raw fastq files were used in this study. Illumina sequencing adaptors from raw mRNA-seq data of asymptomatics individuals, visceral leishmaniasis patients before and after treatment were trimmed and the low-quality reads were filtered using Trimmomatic v. 0.39 [4] with the following parameters: LEADING:3 TRAILING:3 SLIDINGWINDOW:4:20 CROP:100 (or CROP:125). An average of 92.85 % of raw paired-end reads were kept during the trimming process. An average of 29 million high quality reads per sample were used for dual mapping procedure.

Genome and annotation indexes were generated through the concatenation of Leishmania infantum GCA_900500625.1) and Homo sapiens GRCh38.p13 (available at https://protists.ensembl.org/Leishmania_infantum_gca_900500625/Info/Index) (available at http://www.ensembl.org/Homo_sapiens/Info/Index) files obtained from ENSEMBL database. High quality reads were then aligned using STAR aligner v.2.7.10a [5]. Alignments were run using these combined parasite and human references using ––outFilterMatchNmin 40 to locally align to account for splice leader sequences within parasite transcripts, which may otherwise be discarded [6]. Other STAR alignment parameters as follows: –outFilterMultimapNmax 20 –outFilterMismatchNmax 15 –alignSJoverhangMin 8 –alignMatesGapMax 1000000 ––outFilterMatchNmin 40 –quantMode GeneCounts. The parasite and human counting number of reads per gene were accessed with –quantMode GeneCounts option during the alignment.

The percentage of reads aligned in each genome was calculated using read count files from STAR output (available at Mendeley Data, Reserved DOI:10.17632/2xwjzjzvyn.1). The annotation for L. infantum genes was performed using the TriTryp database [7]. The read count data were also used to ascertain the read overlaps across samples per group using Venn diagrams (available at https://bioinformatics.psb.ugent.be/webtools/Venn/). In the INPUT section, the list of gene IDs with read count > 0 per sample was used. This was executed for all samples per group. The Venn diagram output was a list of genes in a text file showing which genes are shared per sample.

Ethics Statements

All procedures performed were approved by the Ethics Committee of the Federal University of Sergipe (CAAE: 04587312.2.0000.0058) according to the recommendations of the Brazilian Human Research Ethics Evaluation System (CEP/CONEP). All subjects or their legal guardians signed an informed consent form previous to the study.

CRediT authorship contribution statement

Ellen Gomes: Methodology, Formal analysis, Visualization, Writing – original draft. Luana Aparecida Rogerio: Formal analysis, Visualization, Writing – original draft. Nayore Tamie Takamiya: Formal analysis, Visualization. Caroline Torres: Formal analysis, Visualization. João Santana da Silva: Methodology, Resources, Writing – review & editing. Roque Pacheco Almeida: Methodology, Resources, Writing – review & editing. Sandra Regina Maruyama: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration, Funding acquisition.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

We thank Iran Malavazi, Anderson Ferreira Cunha and Felipe Roberti Teixeira for their generous and continuing support. This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP agreements 2016/20258-0 Young Investigator Award to Sandra Regina Maruyama) and 2013/08216-2 (Center for Research in Inflammatory Diseases); from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES, Finance code 001) and from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, grant no. 552721/2011-5). SRM received a fellowship from FAPESP (2017/16328-6). Scholarships from FAPESP were awarded to LAR (2020/14011-8), NTT (2021/12464-8), EG (2022/01525-9) and CT (2021/10358-6).

Data Availability

References

  • 1.Maruyama S.R., Fuzo C.A., Oliveira A.E.R., Rogerio L.A., Takamiya N.T., Pessenda G., de Melo E.V., da Silva A.M., Jesus A.R., Carregaro V., Nakaya H.I., Almeida R.P., da Silva J.S. Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection. Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.784463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Burza S., Croft S.L., Boelaert M. Leishmaniasis. The Lancet. 2018;392:951–970. doi: 10.1016/S0140-6736(18)31204-2. [DOI] [PubMed] [Google Scholar]
  • 3.Moulik S., Sengupta S., Chatterjee M. Molecular Tracking of the Leishmania Parasite. Front. Cell. Infect. Microbiol. 2021;11 doi: 10.3389/fcimb.2021.623437. https://www.frontiersin.org/articles/10.3389/fcimb.2021.623437 accessed August 3, 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.USADELLAB.org - Trimmomatic: A flexible read trimming tool for Illumina NGS data, (n.d.). http://www.usadellab.org/cms/?page=trimmomatic (accessed August 3, 2022).
  • 5.Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: ultrafast universal RNA-seq aligner. Bioinforma. Oxf. Engl. 2013;29:15–21. doi: 10.1093/bioinformatics/bts635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Forrester S., Goundry A., Dias B.T., Leal-Calvo T., Moraes M.O., Kaye P.M., Mottram J.C., Lima A.P.C.A. Tissue Specific Dual RNA-Seq Defines Host-Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum. Microbiol. Spectr. 2022;10 doi: 10.1128/spectrum.00679-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Aslett M., Aurrecoechea C., Berriman M., Brestelli J., Brunk B.P., Carrington M., Depledge D.P., Fischer S., Gajria B., Gao X., Gardner M.J., Gingle A., Grant G., Harb O.S., Heiges M., Hertz-Fowler C., Houston R., Innamorato F., Iodice J., Kissinger J.C., Kraemer E., Li W., Logan F.J., Miller J.A., Mitra S., Myler P.J., Nayak V., Pennington C., Phan I., Pinney D.F., Ramasamy G., Rogers M.B., Roos D.S., Ross C., Sivam D., Smith D.F., Srinivasamoorthy G., Stoeckert C.J., Jr, Subramanian S., Thibodeau R., Tivey A., Treatman C., Velarde G., Wang H. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res. 2010;38:D457–D462. doi: 10.1093/nar/gkp851. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement


Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES